Literature DB >> 23866299

Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?

Lisa Longato1.   

Abstract

The global diffusion of the so-called Western diet, which is enriched in fat and carbohydrates, such as fructose, has been proposed to be an underlying cause of the increased prevalence of metabolic conditions, including non-alcoholic fatty liver disease (NAFLD). This Smart Card summarizes the main metabolic and hepatic histological features of rodent models fed with diets combining high fat and fructose.

Entities:  

Year:  2013        PMID: 23866299      PMCID: PMC3735407          DOI: 10.1186/1755-1536-6-14

Source DB:  PubMed          Journal:  Fibrogenesis Tissue Repair        ISSN: 1755-1536


Introduction

Non-alcoholic fatty liver disease (NAFLD), a condition regarded as the hepatic manifestation of the metabolic syndrome, currently represents the most common cause of chronic liver disease [1]. The condition ranges from simple hepatic fat accumulation (steatosis) to non-alcoholic steatohepatitis, where fat is accompanied by hepatocyte injury, and necroinflammation. This condition poses an increased risk of cirrhosis and hepatocellular carcinoma [1]. The dramatic increase in prevalence of obesity, metabolic syndrome, and NAFLD has been linked to the global diffusion of the Western diet, characterized by excess caloric intake due to increased consumption of processed food and beverages, coupled with a more sedentary lifestyle [2,3]. This has led to a significant increase in sucrose and high-fructose corn syrup consumption, both of which contain similar amounts of glucose and fructose [4]. In the USA, for example, fructose consumption has more than doubled in the last three decades [3]. Excessive fructose consumption has been linked to an increased prevalence of metabolic diseases and growing evidence suggests that it may also contribute to the development and severity of NAFLD by exacerbating fat deposition, inflammation, and, possibly fibrosis [5]. Mechanistically, fructose may contribute to NAFLD by promoting de-novo lipogenesis, insulin resistance, oxidative stress, bacterial overgrowth, and inflammation [3-7]. The mechanisms responsible for transition to non-alcoholic steatohepatitis are still not completely understood, in part because of the scarcity of animal models that can fully replicate both the histological and metabolic features of human non-alcoholic steatohepatitis [8]. As fructose is likely to act as a dietary ‘second hit’ [5], effort has recently been put into developing novel experimental models to recapitulate the Western diet by combining high-fat or high-energy diets and fructose. The aim of this Smart Card is to provide a synthetic and exhaustive source for rapid consultation of the currently proposed rodent models of diets combining high fat and fructose, summarizing the metabolic and hepatic consequences of such combinations (Table 1).
Table 1

Metabolic and hepatic features of rodent models fed with diets combining high fat and fructose

Name of model, species, or strainDietWeeksMetabolic featuresaNAFLD featuresa 
ALIOS diet (long-chain saturated trans fat)
Standard chow (13.6% kcal from fat (soybean oil (15% saturated fatty acids, 23% monounsaturated fatty acids, 61% polyunsaturated fatty acids)) + gel-water;
16
↑ body weight, ↑ liver weight;
↑ alanine aminotransferase, ↑ aspartate aminotransferase;
[9]
C57BL/6 J mouse
Alios diet: 45% kcal from fat (30% from partially hydrogenated vegetable oil (28% saturated fatty acids, 57% monounsaturated fatty acids, 13% polyunsaturated fatty acids) + high-fructose corn syrup equivalent (55% fructose, 45% glucose by weight) (42 g/l as gel-water)
↑ liver triglycerides;
macrosteatosis (zones 1 and 2), microsteatosis (zone 3);
↑ insulin, ↑ leptin;
 
 
= adiponectin;
lobular inflammation;
 
 
= triglycerides, ↑ cholesterol (plasma)
possible ballooning or Mallory-Denk body fibrosis: not observed
Modified ALIOS
Chow diet;
16
↑ body weight, ↑ liver weight;
↑ alanine aminotransferase;
[10]
(medium chain saturated fatty acids)
High-fat diet (58% kcal from fat);
↑ glucose/insulin (fasting);
steatosis (micro, macro);
C57BL/6 J mouse
High-fat diet + water with high-fructose corn syrup equivalent (55% fructose and 45% sucrose by weight (42 g/l))
↑ HOMA-IR;
lobular inflammation, ↑ apoptosis;
 
 
↑ liver triglycerides
ballooning: not assessed or not reported;
 
 
 
↑ fibrosis
Fast-food mouse
Standard chow (13% kcal from fat (1% saturated fatty acids) + high-fructose corn syrup in water (42 g/l));
25
↑ body weight, ↑ liver weight;
↑ aspartate
[8]
C57BL/6 J mouse
High-fat diet (60% kcal from fat (1% saturated fatty acids) + high-fructose corn syrup in water (42 g/l));
↑ glucose, insulin (fasting);
aminotransferase;
 
Fast-food diet (40% kcal from fat (12% saturated fatty acids) +2% cholesterol + high-fructose corn syrup in water (42 g/l))
↑ HOMA-IR;
steatosis: panacinar;
 
 
↓ adiponectin;
(++ macro, + micro);
 
 
↑ cholesterol (plasma)
intra-acinar inflammation;
 
 
 
ballooning;
fibrosis: peri-sinusoidal, -cellular
High-fat diet + fructose (water)
Control diet (4.8% fat);
8
↑ body weight, = liver weight;
Liver function tests: not assessed or not reported;
[11]
C57BL/6 J mouse
60% fat diet + 30% fructose in water
↑ glucose, ↑insulin (fasting);
centrilobular fat vacuolation;
 
 
↑ HOMA-IR, ↑ GTT-AUC;
(↑ Oil Red O);
 
 
↑ leptin;
fibrosis: not assessed or not reported
 
 
↑ triglycerides (plasma), ↑ cholesterol (plasma)
 
High-fat diet + sucrose
Control group (control);
12
↑ body weight;
Liver function tests: not assessed or not reported;
[12]
Wistar rats
High fat, high sucrose
=glucose, = insulin;
↑ macrosteatosis
 
 
↑ cholesterol, = triglycerides (plasma);
 
 
 
↑ leptin
 
High-fat diet + fructose (water)
Control diet;
8
↑ body weight, ↑ liver weight;
Liver function tests: not assessed or not reported;
[13]
C57BL6/J mouse
High-fat diet (72% fat (corn oil/lard); 28% protein, <1% carbohydrates) + 21% fructose in water
= liver triglycerides, ↑ GTT-AUC;
↑ macrosteatosis;
 
 
=glucose, ↑ insulin (fasting)
fibrosis: not assessed or not reported
High-fat diet + fructose (water)
Standard chow (5% kcal from fat, 18% proteins, 77% carbohydrates)
12
↑ body weight;
↑ alanine aminotransferase;
[14]
Sprague–Dawley rat
Standard chow + fructose in water (30% w/v);
glucose =, ↑ insulin;
ballooning + mild steatosis;
 
High-fat diet (58% kcal from fat, 18% protein, 24% carbohydrates)
↑ triglycerides, ↑ cholesterol (plasma)
no inflammation;
 
High-fat diet + fructose in water (30% w/v)
 
rare fibrosis
High-fat diet + fructose (water)
Standard chow (24% protein, 11% fat, 65% carbohydrates (% by weight));
15
↑ body weight, ↑ liver weight;
↑ alanine aminotransferase, ↑ aspartate aminotransferase;
[15]
Wistar rats
High-fat diet [26% fat, 17% protein, 4% cholesterol, 53% carbohydrates) + 10% (w/v) fructose in water
↑ liver triglycerides, ↑ HOMA-IR;
↑ Oil Red O;
 
 
↑ insulin, = glucose (fasting);
fibrosis: not assessed or not reported
 
 
↑ leptin, ↓ adiponectin
 
High-fat diet + fructose (water)
Normal chow (4% fat);
48
↑ body weight, ↑ liver weight;
Liver function tests, fibrosis: not assessed or not reported;
[16]
Sprague–Dawley rats
High-fat diet (60% kcal from fat) + 10% fructose in water
= glucose (fasting), ↑ GTT-AUC;
macroscopic signs of steatosis
 
 
↑ triglycerides, = cholesterol (plasma)
 
High-fat diet + fructose (water)
Low-fat diet: 10% kcal from fat;
10
↑ Body weight, ↑ liver weight;
↑ alkaline phosphatase, = alanine aminotransferase;
[17]
Sprague–Dawley rats
Western diet: high-fat diet (45% kcal from fat (soybean oil, lard)) + high-fructose corn syrup-55 (55% fructose, 45% glucose diluted with water to 12.5%)
↑ GTT-AUC/↑ leptin;
↑ liver fat score, ↑ NAFLD activity score;
 
 
= triglycerides (plasma);
= lobular inflammation, = ballooning;
 
 
↓ cholesterol (plasma)
fibrosis: no
High-fat diet + fructose (water)
Cornstarch diet;
16
↑ body weight, = liver weight;
↑ alanine aminotransferase /↑ aspartate aminotransferase;
[18]
Wistar rats
High-fat, fructose diet (52% carbohydrate, 24% fat, 25% fructose in drinking water)
↑ basal glucose;
↑ fat vacuoles;
 
 
↑ plasma triglycerides (plasma)
↑ portal inflammation;
 
 
 
fibrosis: portal
High-fat diet + fructose (chow)
Standard chow;
16
↑ body weight, ↑ liver weight;
↑ alanine aminotransferase/ aspartate aminotransferase;
[19]
C57BL/6 J mice
High-fat, high-fructose diet (in solid diet)
↑ HOMA-IR;
micro/macro-steatosis (pericentral);
 
↑ insulin, glucose (fasting);
fibrosis: not assessed or not reported
 
↑ liver triglycerides
 
High-fat diet + fructose (chow)
Control group (cornstarch diet);
5
= body weight;
= alanine aminotransferase;
[20]
High fructose (70% by weight);
= plasma triglycerides;
some macrosteatosis;
Wistar rats
High sucrose (70%);
= glucose;
inflammation: =lobular, = portal;
High fat (15%);
= liver triglycerides
fibrosis: no change
High fat (15%), high fructose (50%)
 
 
High-fat diet + fructose (chow)
Low-fat, high-carbohydrate (cornstarch) diet;
32
↑ body weight, ↑ liver weight;
↑ alanine aminotransferase, alkaline phosphatase;
[21]
Wistar rats
High-carbohydrate (fructose/sucrose), high-fat diet
↑ visceral adiposity;
= liver triglycerides, lipid deposition;
 
↑ % body fat
inflammation;
 
 
fibrosis: not assessed or not reported
High-fat diet + fructose (chow + water)
Control: cornstarch diet;
16↑ body weight, ↑ liver weight;
↑ alanine aminotransferase, ↑ aspartate aminotransferase, ↑ alkaline phosphatase;
[22]
Wistar rats
High-carbohydrate, high-fat diet (including condensed milk (39.5%), beef tallow (20%), and fructose (17.5%)) + 25% fructose in water
↑ glucose, = insulin (fasting);
↑ macrosteatosis;
 
 
↑ GTT-AUC;
↑ inflammation;
  ↑ cholesterol, ↑ triglycerides (plasma)mild portal fibrosis

aAll indicated changes refer to the experimental group in bold compared with either a control diet or other listed groups.

Metabolic and hepatic features of rodent models fed with diets combining high fat and fructose aAll indicated changes refer to the experimental group in bold compared with either a control diet or other listed groups.

Abbreviations

GTT-AUC: Glucose tolerance test: area under the curve; HOMA-IR: Homeostasis model of assessment - insulin resistance; NAFLD: Non-alcoholic fatty liver disease; w/v: Weight by volume.

Competing interests

The author declares that she has no competing interest.
  22 in total

1.  Caffeine attenuates metabolic syndrome in diet-induced obese rats.

Authors:  Sunil K Panchal; Weng-Yew Wong; Kate Kauter; Leigh C Ward; Lindsay Brown
Journal:  Nutrition       Date:  2012-06-19       Impact factor: 4.008

2.  Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats.

Authors:  Hemant Poudyal; Fiona Campbell; Lindsay Brown
Journal:  J Nutr       Date:  2010-03-24       Impact factor: 4.798

Review 3.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 4.  The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.

Authors:  Kyoko Nomura; Toshikazu Yamanouchi
Journal:  J Nutr Biochem       Date:  2011-11-29       Impact factor: 6.048

Review 5.  Review article: fructose in non-alcoholic fatty liver disease.

Authors:  Y Yilmaz
Journal:  Aliment Pharmacol Ther       Date:  2012-04-02       Impact factor: 8.171

6.  SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.

Authors:  Manuela Aragno; Chiara E Tomasinelli; Ilenia Vercellinatto; Maria G Catalano; Massimo Collino; Roberto Fantozzi; Oliviero Danni; Giuseppe Boccuzzi
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

7.  Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems.

Authors:  C Feillet-Coudray; T Sutra; G Fouret; J Ramos; C Wrutniak-Cabello; G Cabello; J P Cristol; C Coudray
Journal:  Free Radic Biol Med       Date:  2008-12-10       Impact factor: 7.376

Review 8.  Dietary fructose in nonalcoholic fatty liver disease.

Authors:  Miriam B Vos; Joel E Lavine
Journal:  Hepatology       Date:  2013-05-01       Impact factor: 17.425

9.  Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

Authors:  Laura H Tetri; Metin Basaranoglu; Elizabeth M Brunt; Lisa M Yerian; Brent A Neuschwander-Tetri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-04       Impact factor: 4.052

10.  High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.

Authors:  Hiroyuki Tsuchiya; Yu Ebata; Tomohiko Sakabe; Susumu Hama; Kentaro Kogure; Goshi Shiota
Journal:  Metabolism       Date:  2012-07-30       Impact factor: 8.694

View more
  17 in total

1.  Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.

Authors:  Xiaoying Liu; Anne S Henkel; Brian E LeCuyer; Matthew J Schipma; Kristy A Anderson; Richard M Green
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-15       Impact factor: 4.052

2.  Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.

Authors:  Brett M McGettigan; Rachel H McMahan; Yuhuan Luo; Xiaoxin X Wang; David J Orlicky; Cara Porsche; Moshe Levi; Hugo R Rosen
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

3.  Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.

Authors:  Janin Henkel; Charles Dominic Coleman; Anne Schraplau; Korinna Jӧhrens; Daniela Weber; José Pedro Castro; Martin Hugo; Tim Julius Schulz; Stephanie Krämer; Annette Schürmann; Gerhard Paul Püschel
Journal:  Mol Med       Date:  2017-03-21       Impact factor: 6.354

4.  The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics.

Authors:  Mohammad Mehdi Ommati; Huifeng Li; Akram Jamshidzadeh; Fereshteh Khoshghadam; Socorro Retana-Márquez; Yu Lu; Omid Farshad; Mohammad Hasan Nategh Ahmadi; Ahmad Gholami; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-07       Impact factor: 3.000

5.  The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig.

Authors:  Ousseynou Sarr; Alexandra Blake; Jennifer A Thompson; Lin Zhao; Katherine Rabicki; Joanna C Walsh; Ian Welch; Timothy R H Regnault
Journal:  J Physiol       Date:  2016-02-17       Impact factor: 5.182

6.  Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.

Authors:  Komal Sodhi; Nitin Puri; Gaia Favero; Sarah Stevens; Charles Meadows; Nader G Abraham; Rita Rezzani; Hayden Ansinelli; Edward Lebovics; Joseph I Shapiro
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

7.  Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.

Authors:  Annayya R Aroor; Javad Habibi; David A Ford; Ravi Nistala; Guido Lastra; Camila Manrique; Merlow M Dunham; Kaitlin D Ford; John P Thyfault; Elizabeth J Parks; James R Sowers; R Scott Rector
Journal:  Diabetes       Date:  2015-01-20       Impact factor: 9.461

8.  MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.

Authors:  Alessandra Tessitore; Germana Cicciarelli; Filippo Del Vecchio; Agata Gaggiano; Daniela Verzella; Mariafausta Fischietti; Valentina Mastroiaco; Antonella Vetuschi; Roberta Sferra; Remo Barnabei; Daria Capece; Francesca Zazzeroni; Edoardo Alesse
Journal:  BMC Cancer       Date:  2016-01-05       Impact factor: 4.430

9.  Exposure to a northern contaminant mixture (NCM) alters hepatic energy and lipid metabolism exacerbating hepatic steatosis in obese JCR rats.

Authors:  Ryan J Mailloux; Maria Florian; Qixuan Chen; Jin Yan; Ivan Petrov; Melanie C Coughlan; Mahemuti Laziyan; Don Caldwell; Michelle Lalande; Dominique Patry; Claude Gagnon; Kurtis Sarafin; Jocelyn Truong; Hing Man Chan; Nimal Ratnayake; Nanqin Li; William G Willmore; Xiaolei Jin
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

10.  Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model.

Authors:  Alessandra Tessitore; Valentina Mastroiaco; Antonella Vetuschi; Roberta Sferra; Simona Pompili; Germana Cicciarelli; Remo Barnabei; Daria Capece; Francesca Zazzeroni; Carlo Capalbo; Edoardo Alesse
Journal:  Oncotarget       Date:  2017-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.